ADHD
ADHD Treatment in Children: What the Evidence and Guidelines Say
What the guideline recommends at each age — and why parent training comes before medication under six.
- Expert Reviewed
- Evidence Based
- Patient Focused
Treatment for childhood ADHD depends heavily on age. The American Academy of Pediatrics' 2019 clinical practice guideline recommends parent training in behavior management and behavioral classroom interventions as the first-line treatment for children aged four to six — before medication is considered. For children aged six to twelve, it recommends FDA-approved medication alongside behavioral interventions. For adolescents aged twelve to eighteen, it recommends medication with the young person's own assent, plus behavioral or training interventions. The guideline also emphasizes screening for conditions that can mimic or accompany ADHD — including anxiety, learning disorders, and sleep apnea — before or alongside treatment.
ADHD treatment by age: what the AAP guideline recommends
The AAP's guidance is not one recommendation. It's three, and the differences matter.
ADHD treatment for ages 4 to 6: behavioral treatment first
Parent training in behavior management (PTBM) and/or behavioral classroom interventions are the recommended first-line treatment — the AAP grades this a strong recommendation. Medication is considered only if behavioral intervention hasn't produced significant improvement and the child's functioning remains moderately to severely disturbed. The guideline names methylphenidate for that situation.
One practical complication the guideline acknowledges: where evidence-based behavioral treatment isn't available — and in many areas it isn't — the clinician has to weigh the risks of starting medication before age six against the harm of delaying treatment. That's a real decision, worth asking about directly if you're being offered medication for a preschooler.
Honest caveat: in the preschool treatment research (PATS), only about one in seven children improved enough with a short parent-training program alone to avoid medication; the majority still had significant symptoms. First-line doesn't mean sufficient for everyone.
ADHD treatment for ages 6 to 12: medication plus behavioral treatment
The guideline recommends FDA-approved ADHD medication alongside parent training in behavior management and/or behavioral classroom interventions — preferably both, not one or the other.
ADHD treatment for ages 12 to 18: medication with the teen's assent
The wording matters. "With the adolescent's assent" means the young person has a say. A teenager who doesn't want to take medication, or who has concerns about how it makes them feel, is a participant in the decision rather than a passenger. Behavioral and organizational-skills interventions are encouraged alongside.
What is parent training in behavior management for ADHD?
Named as first-line for preschoolers and recommended alongside medication for everyone else — and most parents have never had it explained.
It is not parenting classes, and it isn't a suggestion you've done something wrong. It's structured training in a specific set of techniques for managing behavior in a child whose brain regulates attention and impulse differently. Typically 8 to 16 sessions, delivered to parents rather than to the child.
What it covers: giving instructions in a way that works, structured attention and praise, consistent and predictable consequences, planning ahead for difficult situations, and reducing conflict cycles.
Ask specifically for an evidence-based program. Several named programs have research behind them; general parenting advice doesn't. Ask which one, and what the evidence is.
ADHD medication for children: the main types and what to expect
This section explains what the classes are and what to expect. It does not include doses or recommend specific medications — those decisions belong with the prescriber.
Stimulants — methylphenidate-based and amphetamine-based. These are the most-studied ADHD medications and among the most effective treatments in child psychiatry by effect size. They work quickly, often within days, so a trial gives an answer relatively fast.
Non-stimulants — including atomoxetine, guanfacine, clonidine, and viloxazine. Slower to take effect, sometimes over weeks. Used when stimulants aren't tolerated, aren't effective, or aren't appropriate for other reasons.
What ADHD medication does and doesn't do
It can improve attention, reduce impulsivity, and reduce hyperactivity. Many children and parents describe the difference as substantial.
It doesn't teach skills. It doesn't organize a backpack, build a homework routine, or repair a strained relationship with a teacher. That's why the guideline recommends behavioral intervention alongside rather than instead — and why "the medication isn't working" sometimes means "the medication is working and the skills still need building."
ADHD medication side effects to discuss with the prescriber
Reduced appetite, difficulty falling asleep, headaches, and irritability as the dose wears off are all documented and all worth asking about, as are modest reductions in growth velocity. Cardiovascular history and a physical exam should be reviewed before starting — a routine ECG isn't required in the absence of risk factors.
On a common worry: parents frequently ask whether treating ADHD with stimulants increases later substance use risk. It's a well-studied question — raise it directly with the prescriber, who can give you the current evidence.
What should be ruled out before ADHD treatment starts?
The AAP guideline is explicit that evaluation should screen for coexisting conditions — including anxiety, depression, oppositional defiant disorder, conduct disorder, substance use, learning and language disorders, autism, tics, and sleep apnea.
Sleep apnea, the most commonly missed condition to rule out
Poor sleep in children looks like hyperactivity and inattention rather than tiredness. If your child snores most nights, breathes through their mouth, or you've noticed pauses in their breathing, say so during the assessment. See nighttime drooling and mouth breathing.
Others worth raising:
- Hearing. Undetected hearing difficulty looks like not listening. See auditory processing.
- Sensory processing. A child spending most of their capacity tolerating a noisy classroom will look inattentive. See ADHD vs sensory processing disorder.
- Learning differences. Avoidance of work that's genuinely too hard reads as inattention. See learning differences.
- Anxiety. Frequently co-occurs and frequently mistaken for ADHD.
None of this means the ADHD diagnosis is wrong. These conditions co-occur constantly. It means a treatment plan built on an incomplete picture will underperform.
How school support fits into ADHD treatment: 504 plans and IEPs
Often the highest-yield part of a treatment plan, and the part families most often have to ask for.
Formal routes in the US: a 504 plan (IEPs and 504 plans) provides accommodations; an IEP provides specialized instruction where ADHD affects educational performance. Request an evaluation in writing: the district must then either seek your consent to evaluate or explain in writing why it will not, and a letter leaves no doubt about when you asked.1
Accommodations commonly used: preferential seating, extended time, movement breaks, chunked instructions, written as well as verbal directions, reduced homework volume, and a quiet space for tests. Behavioral classroom interventions — daily report cards, structured reinforcement, organizational support — are part of the AAP recommendation, not an add-on.
Which ADHD treatments have weaker evidence?
Supplements — omega-3 shows a modest average effect; iron and zinc mainly help children who are deficient, which is why testing should come before supplementing. Most other supplements marketed for focus have weak or no evidence. See supplements for ADHD.
Elimination diets — a small subset of children may respond, but the evidence for broad dietary restriction is limited and the burden on the family is real. Discuss with a clinician rather than trialling independently.
Cognitive training and working-memory programs — improvements tend to appear on the trained task rather than transferring to daily function.
Neurofeedback — studied extensively, results remain contested, and it's expensive.
Exercise and sleep — not treatments in themselves, and genuinely worth attending to. Sleep in particular, given the screening point above.
Questions to ask your child's doctor about ADHD treatment
- What are we treating first, and why that?
- Is behavioral parent training available here, and which program?
- What was screened for during the assessment?
- If we start medication, when will we review, and what would prompt a change?
- What side effects should we watch for, and how do we reach you between appointments?
- What should school be doing, and who arranges it?
- What would tell us this isn't working?
Frequently Asked Questions
Do supplements help ADHD?
Some, modestly, and mainly in children who are deficient. Omega-3 shows a small average effect. Effects are considerably smaller than established treatments, and testing should come before supplementing.
Does my child have to take medication?
No. For preschoolers, behavioral treatment is recommended first. For older children the guideline recommends medication alongside behavioral intervention, and for adolescents it specifies the young person's own assent. It's a decision to make with your clinician.
How quickly does ADHD medication work?
Stimulants typically show effects within days, so a trial gives an answer relatively quickly. Non-stimulants can take several weeks. Your prescriber will set a review point.
Can ADHD be treated without medication?
Behavioral parent training, classroom interventions, and school accommodations all have evidence and are recommended regardless of whether medication is used. For preschoolers, behavioral treatment is the recommended starting point. Whether it's sufficient varies by child.
What is parent training in behavior management?
Structured training for parents in specific behavior-management techniques, usually 8 to 16 sessions delivered to parents rather than the child. It's first-line for preschoolers and recommended alongside medication for older children. Ask for an evidence-based program by name.
What should be checked before starting treatment?
The AAP recommends screening for coexisting conditions including anxiety, depression, learning and language disorders, autism, tics, and sleep apnea. Hearing and sensory processing are also worth raising.
What is the first-line treatment for ADHD in young children?
For children aged four to six, the AAP recommends parent training in behavior management and/or behavioral classroom interventions as first-line treatment, before medication. Medication is considered if behavioral intervention doesn't produce significant improvement and functioning remains substantially affected.
My teenager doesn't want to take medication. Does that matter?
Yes. The AAP guideline specifies medication for adolescents should be prescribed with the young person's assent. Their concerns are part of the decision, and worth raising directly with the prescriber.
Sources
- U.S. Department of Education, Office of Special Education Programs. OSEP Memo 11-07: A Response to Intervention (RTI) Process Cannot Be Used to Delay-Deny an Evaluation for Eligibility under the Individuals with Disabilities Education Act (IDEA). January 21, 2011 (copy published by the Tennessee Department of Education). Checked October 6, 2026.
Show the passageHide the passage
The regulations “allow a parent to request an initial evaluation at any time”; a district that agrees must give notice and obtain consent, and one that refuses “must provide written notice to parents explaining why”; the evaluation is due “within 60 days of receiving parental consent” or within the State’s own timeframe (34 CFR §300.301(c)). - Wolraich ML, Hagan JF, Allan C, Chan E, Davison D, Earls M, et al.; American Academy of Pediatrics. Clinical practice guideline for the diagnosis, evaluation, and treatment of attention-deficit/hyperactivity disorder in children and adolescents. Pediatrics. 2019;144(4):e20192528. doi:10.1542/peds.2019-2528 (PMID 31570648)
- Greenhill L, Kollins S, Abikoff H, McCracken J, Riddle M, Swanson J, et al. Efficacy and safety of immediate-release methylphenidate treatment for preschoolers with ADHD (PATS). Journal of the American Academy of Child & Adolescent Psychiatry. 2006;45(11):1284–1293. doi:10.1097/01.chi.0000235077.32661.61 (PMID 17023867)
- American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, Text Revision (DSM-5-TR). APA Publishing; 2022. ADHD criteria and the change from subtypes to presentations.
Medical disclaimer. This page is for general educational purposes and does not constitute medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider about your child. It does not include medication dosing. Treatment decisions for a child should be made with a qualified clinician who knows their full history. Poison Control: 1-800-222-1222.